None listed
Conditions
Interventions
None listed
Sponsors
Pusan National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult male and female between the ages of 19 and 85 2) Respiratory tuberculosis (pulmonary tuberculosis, endobronchial tuberculosis, laryngeal tuberculosis) 3) Patients who have confirmed M. tuberculosis in sputum or bronchoscopic washing/BAL fluid(culture or TB-PCR) or clinically/radiologically suspected respiratory tuberculosis patients who starting or planning to start tuberculosis treatment (even if tuberculosis is not confirmed bacteriologically at the time of enrollment) 4) Patients who have started tuberculosis treatment for less than 2 weeks (14 days) as of the date of consent can participate in the study
Exclusion criteria
Exclusion criteria: 1) Patients who have already requested a conventional (existing) phenotype drug susceptibility test (M-kit DST) at the time of enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to appropriate treatment in study subjects who changed TB drugs based on QMAC-DST results | — |
Secondary
| Measure | Time frame |
|---|---|
| Turn-around-time of QMAC-DST test;Proportion of subjects with TB drug change based on QMAC-DST results;time to sputum smear conversion;time to sputum culture conversion;Proportion and time to appropriate treatment of subjects who change TB drugs based on Molecular DST results | — |
Countries
Korea, Republic of
Contacts
Public ContactJeongha Mok
Pusan National University Hospital
Outcome results
None listed